Cite

    Brehm, T. et al. (2022). Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants. Journal of medical virology. 94 (10), pp. 5038-5043. [Online].